Related references
Note: Only part of the references are listed.Induction of tumoricidal function in CD4+ T cells is associated with concomitant memory and terminally differentiated phenotype
Daniel Hirschhorn-Cymerman et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Transcription Factor Smad-Independent T Helper 17 Cell Induction by Transforming-Growth Factor-β Is Mediated by Suppression of Eomesodermin
Kenji Ichiyama et al.
IMMUNITY (2011)
4-1BB Triggering Ameliorates Experimental Autoimmune Encephalomyelitis by Modulating the Balance between Th17 and Regulatory T Cells
Young H. Kim et al.
JOURNAL OF IMMUNOLOGY (2011)
CD134 Plus CD137 Dual Costimulation Induces Eomesodermin in CD4 T Cells To Program Cytotoxic Th1 Differentiation
Harry Z. Qui et al.
JOURNAL OF IMMUNOLOGY (2011)
Costimulation Through the CD137/4-1BB Pathway Protects Human Melanoma Tumor-infiltrating Lymphocytes From Activation-induced Cell Death and Enhances Antitumor Effector Function
Jessica Ann Hernandez-Chacon et al.
JOURNAL OF IMMUNOTHERAPY (2011)
Combination CTLA-4 Blockade and 4-1BB Activation Enhances Tumor Rejection by Increasing T-Cell Infiltration, Proliferation, and Cytokine Production
Michael A. Curran et al.
PLOS ONE (2011)
Treatment with anti-CD137 mAbs causes intense accumulations of liver T cells without selective antitumor immunotherapeutic effects in this organ
Juan Dubrot et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
The mTOR Kinase Determines Effector versus Memory CD8+ T Cell Fate by Regulating the Expression of Transcription Factors T-bet and Eomesodermin
Rajesh R. Rao et al.
IMMUNITY (2010)
Naive tumor-specific CD4+ T cells differentiated in vivo eradicate established melanoma
Ying Xie et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Tumor-reactive CD4+ T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts
Sergio A. Quezada et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Constitutive Activation of Wnt Signaling Favors Generation of Memory CD8 T Cells
Dong-Mei Zhao et al.
JOURNAL OF IMMUNOLOGY (2010)
Distal Regions of the Human IFNG Locus Direct Cell Type-Specific Expression
Patrick L. Collins et al.
JOURNAL OF IMMUNOLOGY (2010)
Evaluating the Cellular Targets of Anti-4-1BB Agonist Antibody during Immunotherapy of a Pre-Established Tumor in Mice
Gloria H. Y. Lin et al.
PLOS ONE (2010)
Mechanisms Underlying Lineage Commitment and Plasticity of Helper CD4+ T Cells
John J. O'Shea et al.
SCIENCE (2010)
Tumor Vaccines Expressing Flt3 Ligand Synergize with CTLA-4 Blockade to Reject Preimplanted Tumors
Michael A. Curran et al.
CANCER RESEARCH (2009)
Immune regulation by 4-1BB and 4-1BBL: complexities and challenges
Chao Wang et al.
IMMUNOLOGICAL REVIEWS (2009)
Endogenous 4-1BB Ligand Plays a Critical Role in Protection from Influenza-Induced Disease
Gloria H. Y. Lin et al.
JOURNAL OF IMMUNOLOGY (2009)
IL-27 Is a Key Regulator of IL-10 and IL-17 Production by Human CD4+ T Cells
Gopal Murugaiyan et al.
JOURNAL OF IMMUNOLOGY (2009)
4-1BB Functions As a Survival Factor in Dendritic Cells
Beom K. Choi et al.
JOURNAL OF IMMUNOLOGY (2009)
IL-27 Blocks RORc Expression to Inhibit Lineage Commitment of Th17 Cells
Caroline Diveu et al.
JOURNAL OF IMMUNOLOGY (2009)
The promise of 4-1BB (CD137)-mediated immunomodulation and the immunotherapy of cancer
David H. Lynch
IMMUNOLOGICAL REVIEWS (2008)
STAT3 is indispensable to IL-27-mediated cell proliferation but not to IL-27-induced Th1 differentiation and suppression of proinflammatory cytokine production
Toshiyuki Owaki et al.
JOURNAL OF IMMUNOLOGY (2008)
Anomalous type 17 response to viral infection by CD8+ T cells lacking T-bet and eomesodermin
Andrew M. Intlekofer et al.
SCIENCE (2008)
IL-27 inhibits the development of regulatory T cells via STAT3
Magdalena Huber et al.
INTERNATIONAL IMMUNOLOGY (2008)
Cutting edge: A key pathogenic role of IL-27 in T cell-mediated hepatitis
Juergen Siebler et al.
JOURNAL OF IMMUNOLOGY (2008)
Established B16 tumors are rejected following treatment with GM-CSF-secreting tumor cell immunotherapy in combination with anti-4-1BB mAb
Betty Li et al.
CLINICAL IMMUNOLOGY (2007)
Combination therapy with anti-CTL antigen-4 and anti-4-1BB antibodies enhances cancer immunity and reduces autoimmunity
Ergun Kocak et al.
CANCER RESEARCH (2006)
4-1BB-mediated amelioration of experimental autoimmune uveoretinitis is caused by indoleamine 2,3-dioxygenase-dependent mechanisms
Beorn K. Choi et al.
CYTOKINE (2006)
Administration of agonistic anti-4-1BB monoclonal antibody leads to the amelioration of inflammatory bowel disease
J Lee et al.
IMMUNOLOGY LETTERS (2005)
Augmentation of effector CD8+ T cell generation with enhanced granzyme B expression by IL-27
N Morishima et al.
JOURNAL OF IMMUNOLOGY (2005)
4-1BB (CD137) is required for rapid clearance of Listeria monocytogenes infection
SC Lee et al.
INFECTION AND IMMUNITY (2005)
SPI-CI and SPI-6 cooperate in the protection from effector cell-mediated cytotoxicity
M Bots et al.
BLOOD (2005)
4-1BB-mediated immunotherapy of rheumatoid arthritis
SK Seo et al.
NATURE MEDICINE (2004)
IL-27 regulates IL-12 responsiveness of naive CD4+ T cells through Stat1-dependent and -independent mechanisms
S Lucas et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Reprogramming of IL-10 activity and signaling by IFN-γ1
C Herrero et al.
JOURNAL OF IMMUNOLOGY (2003)
Costimulatory molecule-targeted antibody therapy of a spontaneous autoimmune disease
YL Sun et al.
NATURE MEDICINE (2002)
Immune responses in 4-1BB (CD137)-deficient mice
BS Kwon et al.
JOURNAL OF IMMUNOLOGY (2002)
Administration of agonistic anti-4-1BB monoclonal antibody leads to the amelioration of experimental autoimmune encephalomyelitis
YL Sun et al.
JOURNAL OF IMMUNOLOGY (2002)
Expression and function of 4-1BB and 4-1BB ligand on murine dendritic cells
T Futagawa et al.
INTERNATIONAL IMMUNOLOGY (2002)
Share Paper
